Brown dwarfs: too small to be stars, too big to be planets. Only discovered in the 1990s, these in-between cosmic objects aren’t big enough to burn as hot and bright as a true star, instead usually ...

Depression and anxiety disorders are among the most widespread mental health disorders, with estimates suggesting that they affect around 264 million and 284 million people worldwide, respectively.

A Western diet, rich in fat and poor in fiber, can weaken the gut protective mucosa and increase the risk of infection and inflammation. Now, Umeå researchers have identified a milk-derived molecule ...

The James Webb Space Telescope detects methyl cation (CH3+) in a young star system with a protoplanetary disk that is located in the Orion Nebula. Credit: Space.com | imagery courtesy: ESA/Webb, NASA, ...

KYOTO & FUJISAWA, Japan--(BUSINESS WIRE)--xFOREST Therapeutics Co., Ltd. (“xFOREST”) and Axcelead Drug Discovery Partners, Inc. (“Axcelead DDP”) today announced the launch of a joint research ...

In this phase 3, multinational, randomized, double-blind trial, we examined the safety and efficacy of once-daily orforglipron at doses of 6 mg, 12 mg, or 36 mg, as compared with placebo (assigned in ...

In Greek mythology it was Charon, the grim ferryman, who paddled souls across the rivers Styx and Acheron to the underworld. But the real-life ferryman transporting our human souls between the realms ...

WASHINGTON, Aug. 18, 2025 — Acetaminophen is one of the most common painkillers and is found in hundreds of different medications. While safe at recommended doses, acetaminophen overdose is the ...

A new type of all-carbon molecule has been studied under normal room-temperature conditions. This marks only the second time this has ever been done, after spherical buckyballs were synthesised 35 ...

Superluminal to receive payments, equity investment, royalties Lilly, Novo pursuing GPCR-targeting drugs for obesity Superluminal's lead candidate not part of deal with Lilly Aug 14 (Reuters) - Eli ...

More bad news has come down for Biohaven’s small molecule troriluzole. After the FDA decided to convene an advisory committee to consider the asset’s potential approval in a rare disease, pushing the ...